Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Caribou Biosciences, Inc. (CRBU)
|
|
Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 407.7% |
Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -307.7% |
Research and development | 687.2% | 640.0% | 593.7% | 563.0% | 503.6% | 535.7% | 556.7% | 627.6% |
General and administrative | 262.5% | 254.2% | 274.5% | 293.6% | 255.7% | 274.6% | 253.4% | 257.3% |
EBITDA | -837.7% | -784.3% | -759.7% | -749.2% | -650.4% | -702.5% | -702.3% | -781.4% |
Depreciation | 12.0% | 9.9% | 8.5% | | 9.0% | 7.9% | 7.9% | 8.7% |
EBIT | -849.7% | -794.2% | -768.2% | -756.6% | -659.4% | -710.4% | -710.1% | -790.1% |
Pre-tax income | -779.7% | -737.3% | -717.3% | -712.3% | -634.1% | -679.4% | -693.9% | -791.5% |
Income taxes | 0.5% | 0.5% | 0.5% | 2.5% | 2.4% | 3.0% | 3.3% | -4.4% |
Net income | -780.2% | -737.8% | -717.8% | -714.8% | -636.5% | -682.4% | -697.3% | -787.1% |
|